Skip to content

13F-HR/A filed by NOVO HOLDINGS A/S

NOVO HOLDINGS A/S filed this 13F-HR/A for the quarter ended 2014-06-30, filed 2014-11-14, with 10 holding rows worth $1,011,197,000.

Accession
0000950123-14-011903
Filed
2014-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2014

A holdings report, amendment of type new holdings, 10 entries on the cover page, a total value of $1,011,197,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,011,197,000 with VALUE read as thousands by filing date, 13F file number 028-16231. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
VTI922908769COM2,979,100$303,183,000thousands by filing date
OPHTHOTECH CORP683745103COM6,896,819$291,804,000thousands by filing date
Vanguard FTSE Europe ETF922042874SHS2,101,000$125,955,000thousands by filing date
INOGEN INC45780L104COM5,419,449$122,263,000thousands by filing date
ALDER BIOPHARMACEUTICALS INC014339105COM3,201,183$64,248,000thousands by filing date
AKEBIA THERAPEUTICS INC00972D105COMMON STOCK1,516,387$42,140,000thousands by filing date
FLEXION THERAPEUTICS INC33938J106COM1,783,131$24,037,000thousands by filing date
WRIGHT MED GROUP INC98235T107COM585,759$18,393,000thousands by filing date
TETRAPHASE PHARMACEUTICALS INC88165N105COMMON STOCK900,000$12,141,000thousands by filing date
WRIGHT MED GROUP INC98235T115RIGHT 03/01/20194,720,065$7,033,000thousands by filing dateprincipal

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-14-060605 superseded2014-08-14acceptance time not in the bulk data set
13F-HR/A 0000950123-14-011903this filing2014-11-14acceptance time not in the bulk data set